CollPlant Biotechnologies annual total assets
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Total Assets Growth & History (CLGN)
CollPlant Biotechnologies's total assets was $10.8M for fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $10.8M | −$7.9M | −42.36% |
| 2024 | 2024-12-31 | $18.7M | −$15.4M | −45.17% |
| 2023 | 2023-12-31 | $34.1M | −$3.6M | −9.64% |
| 2022 | 2022-12-31 | $37.8M | −$13.5M | −26.27% |
| 2021 | 2021-12-31 | $51.2M | $40.4M | +372.50% |
| 2020 | 2020-12-31 | $10.8M | $89,000 | +0.83% |
| 2019 | 2019-12-31 | $10.8M | $2.0M | +22.85% |
| 2018 | 2018-12-31 | $8.8M | $663,000 | +8.20% |
| 2017 | 2017-12-31 | $8.1M | — | — |
CollPlant Biotechnologies quarterly total assets
Q4.17
Q2.18
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $9.2M | −$8.0M | −46.64% |
| Q4 2025 | 2025-12-31 | $10.8M | −$7.9M | −42.36% |
| Q3 2025 | 2025-09-30 | $14.1M | — | — |
| Q2 2025 | 2025-06-30 | $17.4M | −$9.1M | −34.36% |
| Q1 2025 | 2025-03-31 | $17.2M | — | — |
| Q4 2024 | 2024-12-31 | $18.7M | −$15.4M | −45.17% |
| Q2 2024 | 2024-06-30 | $26.6M | −$15.0M | −36.09% |
| Q4 2023 | 2023-12-31 | $34.1M | −$3.6M | −9.64% |
| Q2 2023 | 2023-06-30 | $41.6M | −$2.8M | −6.40% |
| Q4 2022 | 2022-12-31 | $37.8M | −$13.5M | −26.27% |
| Q2 2022 | 2022-06-30 | $44.4M | −$10.6M | −19.28% |
| Q4 2021 | 2021-12-31 | $51.2M | $40.4M | +372.50% |
| Q2 2021 | 2021-06-30 | $55.0M | $44.1M | +402.56% |
| Q4 2020 | 2020-12-31 | $10.8M | $89,000 | +0.83% |
| Q2 2020 | 2020-06-30 | $10.9M | $1.4M | +14.67% |
| Q4 2019 | 2019-12-31 | $10.8M | $2.0M | +22.85% |
| Q2 2019 | 2019-06-30 | $9.5M | $3.3M | +52.56% |
| Q4 2018 | 2018-12-31 | $8.8M | $663,000 | +8.20% |
| Q2 2018 | 2018-06-30 | $6.3M | — | — |
| Q4 2017 | 2017-12-31 | $8.1M | — | — |
CollPlant Biotechnologies total assets trends
Over the last five fiscal years, CollPlant Biotechnologies's total assets decreased from $10.8M to $10.8M, a change of −$56,000. The latest reported quarter, Q1 2026, shows $9.2M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies source filings ↗